empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Analytical expert of InstaForex
© 2007-2025
Select timeframe
5
min
15
min
30
min
1
hour
4
hours
1
day
1
week
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

US Market News Digest for April 11

After Wednesday's explosive rally triggered by President Donald Trump's announcement of a 90-day tariff pause, US markets on Thursday decided the party was premature. Major indices tumbled: the Dow dropped

Natalia Andreeva 15:28 2025-04-11 UTC+2

Rollercoaster: S&P 500 down 3%, gold hits all-time highs

US stocks fall after Wednesday's events, S&P 500 down 3% European and Asian stocks close higher after Trump suspends most tariffs Bond market rally stabilizes, gold prices hit all-time highs

Thomas Frank 09:44 2025-04-11 UTC+2

Bitcoin struggles to find support as tariff turmoil roils global markets

The flagship cryptocurrency remains in a fragmented state, unable to establish a firm footing. Bitcoin is experiencing significant volatility and posted losses this week. Nevertheless, experts remain optimistic, anticipating

Larisa Kolesnikova 14:38 2025-04-10 UTC+2

US Market News Digest for April 10

The S&P 500 index notched one of its biggest one-day gains in recent months. The upward move slowed near 5,516, but a break above key resistance at 5,669.50 could open

Irina Maksimova 12:58 2025-04-10 UTC+2

Why are stocks rising as yuan sags and U.S. futures slip?

The financial world breathed a sigh of relief on Thursday as stock markets surged higher and the chaotic bond selloff finally slowed down. The reason was a surprise initiative

Thomas Frank 10:17 2025-04-10 UTC+2

US Market News Digest for April 9

US stock indices closed lower after the White House announced a new wave of tariffs on Chinese goods. The rate could rise to 104%, a direct hit on imports

Irina Maksimova 12:33 2025-04-09 UTC+2

Domino effect: US tariffs slam markets, investors dump dollar, bonds

Trump's China tariffs spark recession fears US Treasuries and dollar hit by sell-off, yields soar European stocks fall as US retaliatory tariffs take effect World markets face crisis-era volatility, stocks

Thomas Frank 11:20 2025-04-09 UTC+2

"Golden" Forecasts: Gold at $3,500, $3,700 – Higher and Higher?

Gold forecasts are becoming increasingly dazzling in every sense, as analysts appear to be competing with one another over how high the precious metal could go. Rising geopolitical instability

Larisa Kolesnikova 11:07 2025-04-09 UTC+2

Markets on roller coaster: Dow plummets, gold rallying, Trump keeps investors on edge

The changes in Wall Street indices for the last 24 hours: the S&P 500 fell by 0.23%, the Nasdaq rose by 0.10%, and the Dow dropped by 0.91%. The S&P

12:25 2025-04-08 UTC+2

US Market News Digest for April 8

The Trump administration's latest wave of tariffs is reshaping economic expectations. Goldman Sachs is now forecasting a recession within the next 12 months, while JPMorgan analysts are pricing

Ekaterina Kiseleva 12:14 2025-04-08 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.